XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
about
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerEndoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the UglyHypoxia signaling pathways: modulators of oxygen-related organellesGlycoprotein Quality Control and Endoplasmic Reticulum StressStructure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitorsAdipose tissue dysfunction and its effects on tumor metabolismStress responses from the endoplasmic reticulum in cancerOxidative stress, unfolded protein response, and apoptosis in developmental toxicityEvolution of ramucirumab in the treatment of cancer - A review of literatureState-of-the-art of regulatory dendritic cells in cancerER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell HomeostasisTargeting abnormal ER stress responses in tumors: A new approach to cancer immunotherapyMolecular Pathways: Immunosuppressive Roles of IRE1α-XBP1 Signaling in Dendritic Cells of the Tumor MicroenvironmentCancer: A dendritic-cell brake on antitumour immunityTauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in CancerThe unfolded protein response in immunity and inflammationThe transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcomeUnfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancerMolecular mechanisms of human IRE1 activation through dimerization and ligand bindingData-driven prediction and design of bZIP coiled-coil interactions.ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells.Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease.In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation.Knockdown of XBP1 by RNAi in Mouse Granulosa Cells Promotes Apoptosis, Inhibits Cell Cycle, and Decreases Estradiol Synthesis.Hallmarks of triple negative breast cancer emerging at last?MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.Chemical induction of unfolded protein response enhances cancer cell killing through lytic virus infection.NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancerThe mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cellsUPR, autophagy, and mitochondria crosstalk underlies the ER stress responseGCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF actionEpithelial Xbp1 is required for cellular proliferation and differentiation during mammary gland developmentMetabolic respiration induces AMPK- and Ire1p-dependent activation of the p38-Type HOG MAPK pathway.An unexpected alliance between stress responses to drive oncogenesis.Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.Cripto-1 as a novel therapeutic target for triple negative breast cancer.Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers.HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
P2860
Q26795466-14250A37-AF72-4816-97A9-7A6C40E226A8Q26799567-EB9DC007-808A-4F07-A46E-F36025A0DC85Q26799950-41A453A7-58C0-41CB-B5BD-7BD4C84F1BFAQ26801535-73A575DE-8636-4E8E-A42B-2DA20723FA0EQ27640568-2FEF491D-1CAB-4320-9EAC-D779E1CC71E7Q28080748-ADC08BF4-1DE2-4BEC-A734-E055ACF93BACQ28082709-C3ECA8B2-842C-4BF3-9824-6B8DA577F959Q28084613-1BDD3AD7-212A-4EF0-8CFD-340C04303120Q28276412-D53D4454-3362-4749-A816-FAFCECC76551Q28383942-E4C20B3F-9B40-4D0A-A22F-CF1D922C6006Q28389316-E413F6FB-1BEA-43B2-B58B-48A0BE2A5CCFQ28392706-25EE40B5-9697-471F-9EBA-A8244E87D4E0Q28393599-9E9359EB-8452-4573-B701-D0FDC32E9390Q28397758-DB603B0C-766E-4AA1-B20E-67CBE0FE09CEQ28828990-EF85E0EB-2AB3-48DB-9FDF-1F2D8D0BFCFFQ29248711-A2F0E833-9723-4F30-ABB3-8BF004010B19Q29248713-404639F5-B4D6-4AA6-9619-433CABC9B00BQ29248715-99289C2D-A46E-4220-A5A4-6DD180289439Q29248716-512E2E30-088E-495E-B5F0-060045A5EA9BQ30404387-BD22B722-3222-4CDD-9406-C5368416F8EFQ30895756-CFEFAEC2-F791-4DA5-BA4F-01CF62721250Q33591623-3350EE3B-311A-4955-9737-ACCB23F59FB1Q33653691-EE55F9DF-746C-4EC5-8E11-A9B64A82500AQ33805335-E20A3B62-7CE0-423E-B214-F748FFAFC181Q33831578-EAEF54FC-9061-409E-B7B2-DDA503034C26Q33838535-4217703B-B8C9-4940-8674-3F3CD98B33E7Q34008421-89789789-EE43-40ED-8EB7-CBA67DD76A97Q34439115-6067BD13-BA31-4F0A-869D-F80D8521E633Q34594638-A754BAED-39EC-4A1D-B550-7EE011273537Q34745409-C3E175DE-1E7B-4D82-9488-F0142B519E81Q34807567-377DF531-C4CF-4ABB-893B-3D7BBCD64ED8Q35122358-152BBEF9-FC02-4D42-A2A9-FFDA85D9A07AQ35238447-3C01F36E-F70D-44DA-BCEA-4D51BF0E1FF4Q35288559-EF9095C4-610C-437F-8841-3C33BFBEF876Q35376992-DCB1EAFA-0F00-4ED2-9C65-1914ACCDA7E7Q35599727-4715ACBC-1D9D-450F-8386-EEB583F6256DQ35607012-1A2E9D7E-9D0B-4308-ADE2-1099B99493D9Q35658975-D3194693-CB27-44ED-8873-A33FC43F603DQ35763853-73C0ECE7-ECFB-4961-9950-28EEF7CE41C6Q35828430-1C263897-2B90-4F87-A7FB-99866F82C7D3
P2860
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@ast
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@en
type
label
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@ast
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@en
prefLabel
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@ast
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@en
P2093
P2860
P50
P356
P1433
P1476
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway.
@en
P2093
Dimitrios Iliopoulos
Dorothy Z Hu
Haifa Shen
Laurie H Glimcher
Matthew B Greenblatt
Mauro Ferrari
Melissa D Landis
P2860
P2888
P304
P356
10.1038/NATURE13119
P407
P577
2014-03-23T00:00:00Z